Jakob Dupont

2015 - OncoMed Pharmaceuticals

In 2015, Jakob Dupont earned a total compensation of $1.5M as Former Senior Vice President Chief Medical Officer at OncoMed Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$174,812
Option Awards$884,058
Salary$399,571
Total$1,458,441

Dupont received $884.1K in option awards, accounting for 61% of the total pay in 2015.

Dupont also received $174.8K in non-equity incentive plan and $399.6K in salary.

Rankings

In 2015, Jakob Dupont's compensation ranked 6,128th out of 13,638 executives tracked by ExecPay. In other words, Dupont earned more than 55.1% of executives.

ClassificationRankingPercentile
All
6,128
out of 13,638
55th
Division
Manufacturing
2,290
out of 5,190
56th
Major group
Chemicals And Allied Products
824
out of 1,854
56th
Industry group
Drugs
659
out of 1,528
57th
Industry
Pharmaceutical Preparations
514
out of 1,182
57th
Source: SEC filing on April 13, 2017.

Dupont's colleagues

We found two more compensation records of executives who worked with Jakob Dupont at OncoMed Pharmaceuticals in 2015.

2015

Paul Hastings

OncoMed Pharmaceuticals

Chief Executive Officer

2015

John Lewicki

OncoMed Pharmaceuticals

Executive Vice President, Research and Development

News

In-depth

You may also like